Immunization Financing Outlook: A Historical Perspective

Similar documents
Meeting Nigeria s vaccines financing needs ( )

What is to be done to respond to country needs and comply with WHA and SAGE recommendations?

Paradigm shift: from dependency to country ownership Seth Berkley, MD Chief Executive Officer of the GAVI Alliance

VACCINE MARKETS OVERVIEW SESSION

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

Perspectives on Ensuring Access to Vaccines in Lower Income Countries

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

34th Meeting of the Expert Review Committee on Polio Eradication and Routine Immunization, Nigeria Findings and Recommendations

What are the outputs? What is generated by whom? Decade of Vaccine Economics (DOVE) 18/07/2014

Prioritizing Emergency Polio Eradication Activities

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

PROPOSED 2017 FEDERAL BUDGET FOR IMMUNIZATION AND JUSTIFICATION FOR REQUESTS

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

Gavi Secretariat Update: Progress, priorities and strategies

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Progress with IPV introduction Polio Partners Group PPG 16 June 2014

SUCCESSFULLY TRANSITIONING NIGERIA FROM GAVI SUPPORT

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

Public Disclosure Copy

Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development

Polio and routine immunisation Alan Brooks

GAVI, THE VACCINE ALLIANCE

Polio & routine immunisation Alan Brooks

Overview of Routine Immunization in Nigeria

Gavi s strategic framework 22 June 2016

The use of total funds channelled through "la Caixa" to Gavi programmes in 2017

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

Global Partners' Group

Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting

GAVI, THE VACCINE ALLIANCE

Global vaccine market

2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS

Report to the Board 6-7 June 2018

GAVI Role in IPV Introductions

Report to the GAVI Alliance Board 7-8 July 2011

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

Polio post-certification strategy

UNICEF 2017 VACCINE INDUSTRY CONSULTATION October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark

1. The World Bank-GAVI Partnership and the Purpose of the Review

Gavi s Sustainability and Transition Approach

Gavi initiatives for improving vaccine supply

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

Global Health Policy: Vaccines

Ex post evaluation Tanzania

The Polio Endgame

Vaccine Security UNICEF Vaccine Procurement Overview. Supplier meeting UNICEF Supply Division 3-4 April 2008 Rob Matthews

Expanded Programme on Immunization

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

Global Health Policy: Vaccines

Report to the. GAVI Alliance Board June 2013

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 5. Can my country afford a JE vaccination program?

Report to the Board June 2015

Access to vaccination in GAVI countries and at global level

Exercise: Estimating immunization program costs (~60 minutes)

INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA

China MOH and Sanofi Pasteur Collaborations in Pandemic Preparedness. Presented by

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

Why GAVI Needs to Do More To Ensure Lower Vaccine Prices And How It Could Be Done

Update on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI

Innovative Finance: the power of innovation to save lives

The power of innovation to save lives

Viral Hepatitis Prevention Board CREATIVE FINANCING SOLUTIONS TO SCALE UP PREVENTION & TREATMENT OF HBV/HCV

STATEMENT OF LYNN STRATFORD SENIOR VICE PRESIDENT, PROGRAM AND COMMUNITY ENGAGEMENT UNITED STATES FUND FOR UNICEF

Gavi s private sector engagement approach

The Global Alliance for Improved Nutrition

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Analysis of indicators used in Financial Sustainability Plans submitted to GAVI

Legal framework for the development of commodity based financing. Krassimir Kiriakov International WHR Expert

STRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL ( ) POLICY BRIEF

Vaccines Supply Shortages Challenges & Opportunities

HPV Vaccination. Dr. Vivien Tsu PATH. HPV Vaccination 1

Update from Gavi, the Vaccine Alliance

Targeted Diseases and Immunization. Strategic plan

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

Information for Access

Aboubacar Kampo Chief of Health UNICEF Nigeria

GAVI s Financing for Pneumococcal Vaccines, including the Advance Market Commitment

Report to the. GAVI Alliance Board June 2014

Responding to the SAGE Recommendations on Middle Income Countries Since Sarah Schmitt WHO Consultant

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

MALARIA VACCINE PILOTS

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation

UNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012

Guide on Access to the Yellow Fever ICG Stockpile. Emergency Campaigns. International Coordinating Group on Vaccine. Geneva, Switzerland 2012

The Global Fund & UNICEF Partnership

Saving lives through immunisation A Corporate Social Responsibility approach

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing

Botswana Private Sector Health Assessment Scope of Work

Donor contributions and commitments as of April 2011

International PolioPlus Committee PolioPlus Facts and Figures June Rotary s financial contribution to the polio eradication effort:

Polio and measles control: opportunities and threats for health systems

Transcription:

Immunization Financing Outlook: A Historical Perspective Being a paper presented at the NIFT one day workshop held on 13 th Feb 2017 at Top Galaxy Hotel Kaduna By Ganiyu Salau

Brief History of Immunization Financing in Nigeria Over the years, FGoN has been responsible for the procurement of traditional routine vaccines for the country. While other aspects of immunization activities are receive funding from both the three tiers of government and development partners, The existing sources of immunization financing in the country include: (a) Government sources Federal, States and LGAs annual budgetary appropriation (b) Donor Agencies sources GAVI Alliance WHO, UNICEF, BMGF, Rotary International, CHAI, etc. (c) Loan and grants The World Bank Buy-Down Grant, Japanese Agency for International Development (JICA), KFW, GAC, EU etc. 2003 US$28.7million World bank buy down grant - BMGF 2005 US$51.7million World bank buy down grant - BMGF 2008 US$50.0million World bank buy down grant - BMGF 2010 US$ 60million World bank buy down grant - BMGF 2013 US$95million World bank buy down grant - BMGF 2015 JPY8.285billion JICA loan 2015 US$200million World bank loan 2017 US$125million Proposed World bank loan

S / N YEA R Brief History of Immunization Financing in Nigeria cont RI Component of Capital Budget Non-polio SIA Polio SIA Component of Capital Budget Total 1 2012 6,000,000,000.00 4,485,000,000.00 10,485,000,000.00 2 2013 4,150,000,000.00 4,309,399,324.00 8,459,399,324.00 3 2014 2,156,300,000.00 3,650,775,386.00 5,807,075,386.00 4 2015 2,615,055,925.00 2,568,442,234.00 5,183,498,159.00 5 2016 1,094,468,554.00 1,963,879,269.00 9,821,331,311.00 12,879,679,134.00

Reasons for Funding Gaps & consequent vaccine stocks-out Experienced in the Past REASONS FOR RISING COSTS OF IMMUNIZATION It is important to understand the factors that seek to drive immunization costs during the planned period. They include: The planned Introduction of new and expensive vaccines in line with global trends in immunization service delivery and also to fulfill the save one million lives initiative by government. Such new vaccines planned for introduction (2014 2018) include: PCV (2 nd /3 rd stages), IPV, Rota, Men A, HPV, MR The recent rebasing of the nation s GDP and her subsequent reclassification as a medium income country makes it difficult to grants/funds from certain traditional donor sources. Graduation from GAVI financing GAVI graduation is calculated as 15% increase in GoN co-financing in 2015, and linear increase in co-financing obligation between 2015 co-financing price and the 2020 vaccine price. In 2020, the full market price occurs, and the GoN pays the full cost of vaccines and devices, and average freight; for new vaccines, the ramp-up is from the time of introduction to 5 years after introduction High cost of vaccines including freight and handling charges by procurement agent, Exchange rate instability

The Status of Finances for Immunization in Nigeria overview of Financial requirements of Routing immunization and polio eradication in Nigeria 2016-2020 Year Vaccine supply & logistics (routine only) billion Supplementary immunization Activities billion Total 2016 68 70 138 2017 67 80 147 2018 80 59 139 2019 101 28 129 2020 90 17 107 Total 406 254 660 Source: Nigeria cmyp 2016-2020 billion

2017 IMMUNIZATION FINANCING OUTLOOK S/N (a) (b) BUDGET LINE ROUTINE & NON-POLIO SUPPLEMENTARY VACCINES Sub-Total (Routine Vaccines & Devices) Sub-Total (SIA Vaccines & devices including OPV) Total (RI & Non-polio Supplementary Vaccines/Devices) Polio Eradication Initiative Sub-Total (PEI OPV + Operational Costs) TOTAL CAPITAL BUDGET PROPOSAL FOR 2017 FINANCIAL RESOURCE REQUIREMENTS (CONFIRMED/TENT ATIVE FUNDING) DONOR FUNDS OTHER DONORS (BMGF, EU, GAVI () GAC, KFW, UNICEFetc) 49,520,105,343.44 26,108,600,667.18 0 37,082,875,563.41 32,508,283,999.95 0 87,602,980,906.85 58,616,884,667.13 0 27,083,148,864.39 0 FUNDING SOURCES PROPOSED WBAF () 19,297,383,457.04 937,520,278.05 20,234,903,735.09 8,839,104,783.90 13,384,258,808.20 FGoN FUND GOVERNMENT (2017 BUDGET PROPOSAL) 4,114,122,844.37 3,637,071,285.19 8,751,194,129.56 4,859,785,272.29 113,686,129,771.24 58,616,884,667.13 8,839,104,783.90 33,619,162,543.29 13,610,979,401.85

lans by the Government to Bridge the Immunization Funding Gap in iew of Quantum Jump in Financial Requirement for Immunization in coming years In the recent past significant efforts have been made to bridge the funding gaps for immunization in the country. Some of the steps so far taken include: Presentations to the Budget Office for increased budgetary funding for immunization activities, Advocacy to the National Assembly for increased support for immunization financing, Advocacy to the Governors Forum for increased share states and LGAs budget for immunization services, Private Sector Health Alliance for immunization financing in the country, Individual foundations, Partnership with the National Health Insurance Scheme for increased funding for immunization, The National Health Act, and The establishment of National Vaccines Financing Task Force, etc. Establishment of immunization trust fund Encouraging local vaccine production in Nigeria